Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

FTO-mediated autophagy promotes progression of clear cell renal cell carcinoma via regulating SIK2 mRNA stability
Yawei Xu, Jingcheng Zhou, Lei Li, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 15, pp. 5943-5962
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

Oncofetal protein IGF2BPs in human cancer: functions, mechanisms and therapeutic potential
Tianyu Zhu, Lian‐Lian Hong, Zhi‐Qiang Ling
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 41
TRAF2 promotes M2-polarized tumor-associated macrophage infiltration, angiogenesis and cancer progression by inhibiting autophagy in clear cell renal cell carcinoma
Yawei Xu, Lei Li, Wuping Yang, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 24
RNA N6-methyladenosine modifications in urological cancers: from mechanism to application
Lei Yang, Jianming Ying, Qian Tao, et al.
Nature Reviews Urology (2024) Vol. 21, Iss. 8, pp. 460-476
Closed Access | Times Cited: 6
m6A modified ATG9A is required in regulating autophagy to promote HSCs activation and liver fibrosis
Tingjuan Huang, Ziyi Shang, Lina Nie, et al.
Cellular Signalling (2025), pp. 111619-111619
Closed Access
Deciphering the interplay between SETD2 mediated H3K36me3 and RNA N6-methyladenosine in clear cell renal cell carcinoma (ccRCC)
Shafiq Shaikh, Xia Zhao, Ryan T. Wagner, et al.
Epigenetics (2025) Vol. 20, Iss. 1
Open Access
METTL14‐mediated m6A modification of ZFP14 inhibits clear cell renal cell carcinoma progression via promoting STAT3 ubiquitination
Zhuonan Liu, Tianshui Sun, Zhe Zhang, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 2
Open Access
Novel insights into the interplay between m6A modification and programmed cell death in cancer
Jinhao Chen, Mujie Ye, Jian’an Bai, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 6, pp. 1748-1763
Open Access | Times Cited: 14
Writers, readers, and erasers RNA modifications and drug resistance in cancer
Di Chen, Xinyu Gu, Yeltai Nurzat, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 5
The relationship between the network of non-coding RNAs-molecular targets and N6-methyladenosine modification in tumors of urinary system
Ruiming Li, Zhu Chunming, Yuan Wang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 4
Open Access | Times Cited: 4
Novel Insights into The Roles of N6-methyladenosine (m6A) Modification and Autophagy in Human Diseases
Jiaxin Liang, Jingwen Sun, Wei Zhang, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 2, pp. 705-720
Open Access | Times Cited: 12
Regulatory mechanisms and therapeutic implications of insulin-like growth factor 2 mRNA-binding proteins, the emerging crucial m6A regulators of tumors
Heng Zhou, Qiang Sun, Ming-Liang Feng, et al.
Theranostics (2023) Vol. 13, Iss. 12, pp. 4247-4265
Open Access | Times Cited: 12
The Functional Role and Regulatory Mechanism of FTO m6A RNA Demethylase in Human Uterine Leiomyosarcoma
Qiwei Yang, Ayman Al‐Hendy
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7957-7957
Open Access | Times Cited: 10
Crosstalk between m6A modification and autophagy in cancer
Tao Chen, Liying Zheng, Peiyue Luo, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
N6-methyladenosine (m6A) methylation in kidney diseases: Mechanisms and therapeutic potential
Yuting Sun, De Jin, Ziwei Zhang, et al.
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms (2023) Vol. 1866, Iss. 4, pp. 194967-194967
Open Access | Times Cited: 8
FTO regulates osteoclast development by modulating the proliferation and apoptosis of osteoclast precursors in inflammatory conditions
Jinlin He, Yiqing Zhao, Yiwen Zhang, et al.
Cellular Signalling (2024) Vol. 117, pp. 111098-111098
Closed Access | Times Cited: 2
Demethylases in tumors and the tumor microenvironment: Key modifiers of N6-methyladenosine methylation
Junchen Guo, Liang Zhao, Meiqi Duan, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116479-116479
Open Access | Times Cited: 2
Inhibition of ALKBH5 inhibits inflammation and excessive proliferation by promoting TRIM13 m6A modifications in glomerular mesangial cells
Xingmin Hu, Tao Liu, Xingxing Zhuang, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Open Access | Times Cited: 2
m1A regulator-mediated methylation modification patterns correlated with autophagy to predict the prognosis of hepatocellular carcinoma
Yingmin Wu, Lian Li, Long Wang, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Clinical Perspectives in Epitranscriptomics
Eloy Santos-Pujol, Carlos Quero-Dotor, Manel Esteller
Current Opinion in Genetics & Development (2024) Vol. 87, pp. 102209-102209
Open Access | Times Cited: 2
Histone methyltransferase SETD2: An epigenetic driver in clear cell renal cell carcinoma
Mengxue Yu, Kaiyu Qian, Gang Wang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 6
N6-methyladenosine methylation in kidney injury
Qimeng Wang, Xiaoting Fan, Qinghao Sheng, et al.
Clinical Epigenetics (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 6
FTO facilitates cancer metastasis by modifying the m6A level of FAP to induce integrin/FAK signaling in non-small cell lung cancer
Lirong Gao, Anqi Wang, Yuling Chen, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 6
Knockdown of ADAM8 inhibits the proliferation, migration, invasion, and tumorigenesis of renal clear cell carcinoma cells to enhance the immunotherapy efficacy
Hongchen Qu, Minghuan Mao, Kai Wang, et al.
Translational research (2023) Vol. 266, pp. 32-48
Closed Access | Times Cited: 6
The potential of targeting cuproptosis in the treatment of kidney renal clear cell carcinoma
Guojie Lei, Lusheng Tang, Yanhua Yu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115522-115522
Open Access | Times Cited: 5
The m6A demethylase FTO targets POLQ to promote ccRCC cell proliferation and genome stability maintenance
Yichen He, Yimeng Chen, Zhengsheng Li, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 2
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top